First-of-its-kind global report finds that half of cancers worldwide are linked to preventable risk factors, with smoking, alcohol and obesity as the greatest contributors.
The agency has granted an accelerated approval for trastuzumab deruxtecan (Enhertu) to be used in patients with metastatic non–small cell lung cancer whose tumors have HER2 mutations.
Though the study identified better overall survival among married patients, the findings more likely represent a proxy for a stronger support network rather than an effect from marital status itself.